Jennifer Bradley
Psychiatric/Mental Health · Cedar Rapids, IANPI 1013978089
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,613 of the $66,142 with a category attached, or 93.2%. AbbVie accounts for 98.3% of it on its own, with 13 other manufacturers making up the rest. Among psychiatric/mental health clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $290.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$65K
- Johnson & Johnson$320
- Teva Pharmaceuticals USA, Inc.$213
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$133
- Alkermes, Inc.$126
- E.r. Squibb & Sons, L.L.C.$98
- plus $264 from 8 others
What the payments were for
- Speaking & faculty fees$61,61393%
- Travel & lodging$2,0753%
- Food & beverage$2,2423%
- Education$2130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 177 | $64,989 |
| Johnson & Johnson | 18 | $320 |
| Teva Pharmaceuticals USA, Inc. | 2 | $213 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $133 |
| Alkermes, Inc. | 6 | $126 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Almatica Pharma LLC | 4 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Harmony Biosciences LLC | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$63,191
How this compares
$66,142 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 45 | $537,609 |
| Invega SustennaPaliperidone Palmitate | 172 | $525,569 |
| VraylarCariprazine Hcl | 85 | $125,901 |
| Invega TrinzaPaliperidone Palmitate | 11 | $97,172 |
| Abilify MaintenaAripiprazole | 15 | $39,495 |
| LybalviOlanzapine/Samidorphan Malate | 21 | $34,019 |
| TrintellixVortioxetine Hydrobromide | 23 | $11,301 |
| VyvanseLisdexamfetamine Dimesylate | 17 | $6,745 |
| Paliperidone ErPaliperidone | 53 | $6,456 |
| Clozapine | 53 | $4,820 |
| Divalproex Sodium | 42 | $4,008 |
| Vilazodone Hcl | 23 | $2,820 |
| Lisdexamfetamine Dimesylate | 13 | $2,457 |
| Olanzapine | 79 | $2,265 |
| Atomoxetine Hcl | 29 | $1,911 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $320 | $622,741183 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $213 | $537,60945 claims |
| AbbVieVraylar | $64,989 | $125,90185 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $75 | $39,49515 claims |
| Alkermes, Inc.Lybalvi | $126 | $34,01921 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $25 | $18,04640 claims |
| Almatica Pharma LLCSertraline Hcl | $60 | $815118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Cedar Rapids
- Amy MorinCedar Rapids$24K
- Abbie KelleyCedar Rapids$7K
- Natasha LashCedar Rapids$6K
- Kristina GatesCedar Rapids$6K
- Daniell DarbyshireCedar Rapids$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.